Package
1 × 1.0ml pre-filled syringe
Professional use · Injectable facial implant-biostimulator
SECROCAHA
Cross-linked calcium hydroxyapatite hyaluronic acid gel with lidocaine
1 × 1.0ml syringe
30% CaHA · 70% cross-linked HA (20mg/ml) · Lidocaine 3mg/ml
Clinical profile
Product information
Composition
30% calcium hydroxyapatite microspheres (25–45 µm), 70% cross-linked sodium hyaluronate gel (20mg/ml), phosphate buffer, lidocaine hydrochloride (3mg/ml)
Estimated duration
18–24 months
Application area
Deep and superficial biostimulation, placed subdermally with a cannula (ideally 22G)
Chemical formula
Ca10(PO4)6(OH)2
Treatment areas
Indication
01
Jawline contour definition
02
Posterior midface volume restoration
03
Pre-auricular area
04
Deep dermal and subdermal facial contouring and restoration
Product advantages
What are the advantages of SECRO-CAHA?
01
Immediate improvement: instantly fills lines, wrinkles and depressions and supports sagging tissue
02
Biostimulation: CaHA microspheres stimulate new collagen and elastin for firmer, more elastic skin
03
Long-lasting: a new collagen scaffold anchors the microspheres in place for results beyond normal HA fillers
04
Comfort: integrated lidocaine minimises pain and swelling and shortens treatment time
Filler and biostimulator in one
05
Biocompatible calcium hydroxyapatite, an inherent component of the human body, fully metabolised over time
06
Continued collagen production improves skin quality months after treatment
07
Fanning technique with a 22G cannula for precise subdermal placement